Page Industries Reports Robust Revenue Growth in Latest Quarter Sales Volume Increases US GDP Growth of 2 in Early 2026 Signals Continued Economic Resilience Dating App Authenticity Push Sparks Investor Interest as Startups Tackle Fake Profiles Robert Kiyosaki Predicts Gold at 10000 and Silver 200 Warns of Imminent Stock Market Crash World Cup Campaigns Shaping Consumer Choices in Food Fashion and Travel Italy Stocks End Lower as Investingcom Italy 40 Declines 076 Cohen Steers CNS Q1 2026 Earnings EPS Misses Estimates Amid Market Headwinds UFI Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction SnapOn Q1 2026 Earnings EPS Falls Short of Expectations Shares Edge Higher KEX Q1 2026 Earnings EPS Beats Estimates by 66 Stock Edges Higher CIA Q1 2026 Earnings EPS Miss Triggers Cautious Market Response PERF Q1 2026 Earnings EPS Beats Estimates as Company Delivers Strong Profitability Miluna Acquisition Corp Warrant MMTXW Holds Steady Near Support After Flat Session Rush Street Interactive RSI Holds Above Support After Modest Decline Xtant Medical Holdings XTNT Edges Higher Testing Key Resistance at 050 Gabelli Utility Trust GUT Faces Modest Decline Consolidates Between Key Support and Resistance Franklin Financial Services FRAF Gains Ground Testing Key Levels After 225 Rally Kathleen Kennedy Townsend Secures Buyer for 16 Million Cape Cod Property Amid Strong Coastal Real Estate Demand ADAMH Q1 2026 Earnings Earnings Surge Past Estimates with 75 Surprise Trinity Capital 7875 Notes TRINI Hold Near Par as Income Demand Steadies CDP Q1 2026 Earnings EPS Slightly Beats Estimates on Stable Portfolio Performance RYN Q1 2026 Earnings Stellar EPS Surprise Defies Low Expectations Amcor Q1 2026 Earnings Adjusted EPS Falls Short of Expectations GOTU Q4 2025 Earnings EPS Beat Estimates by 419 Amid Challenging Environment Biogen Q1 2026 Earnings EPS Surges Past Estimates Stock Rises HIVE Digital Technologies Q1 2026 Earnings Significant EPS Miss as Crypto Mining Headwinds Persist SABS Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline